Projected Earnings Date: 2025-11-03    (Delayed quote data   2025-09-16)
Last
 130.10
Change
 ⇓ -0.76   (-0.58%)
Volume
  738,067
Open
 130.90
High
 131.25
Low
 129.66
8EMA (Daily)
 133.19
40EMA (Daily)
 136.54
50EMA (Daily)
 137.16
STO (Daily)
 13.237
MACD Hist (Daily)
 -1.214
8EMA (Weekly)
 135.521
40EMA (Weekly)
 141.99
50EMA (Weekly)
 141.96
STO (Weekly)
 37.952
MACD Hist (Weekly)
 -1.120
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government ( primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com